Fistulizing Crohn's disease

被引：10
|
作者：
Felley, C
Mottet, C
Juillerat, P
Froehlich, F
Burnand, B
Vader, JP
Michetti, P
Gonvers, JJ
机构：
[1] Univ Lausanne, Med Ctr, Div Gastroenterol & Hepatol, CH-1011 Lausanne, Switzerland
[2] Univ Basel, Gastrointestinal Dept, Basel, Switzerland
[3] Univ Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland
来源：
DIGESTION | 2005年 / 71卷 / 01期
关键词：
Crohn's disease; fistula; antibiotics; azathioprine; infliximab; methotrexate; cyclosporine; tacrolimus; internal fistulas; surgery;
D O I：
10.1159/000083868
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Fistulas are common in Crohn's disease. A population-based study has shown a cumulative risk of 33% after 10 years and 50% after 20 years. Perianal fistulas were the most common (54%). Medical therapy is the main option for perianal fistula once abscesses, if present, have been drained, and should include antibiotics ( both ciprofloxacin and metronidazole) and immunomodulators. Infliximab should be reserved for refractory patients. Surgery is often necessary for internal fistulas. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码：26 / 28
页数：3
相关论文
共 50 条
  • [41] Adalimumab as Therapy for Fistulizing Orofacial Crohn's Disease
    Doherty, Glen
    Kalachand, Roshni
    Patchett, Stephen
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (02) : 184 - 185
  • [42] Perianal fistulizing Crohn's disease: A call to action
    Kamm, Michael A.
    Ng, Siew C.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (01) : 7 - 10
  • [43] The management of fistulizing oral Crohn's disease with infliximab
    Staines, K. S.
    Green, R.
    Felix, D. H.
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2007, 36 (07) : 444 - 446
  • [44] Perianal Fistulizing Crohn's Disease: No Shortcuts to a Deep Understanding of the Disease
    Hashash, Jana G.
    Mourad, Fadi H.
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (05) : 1392 - 1393
  • [45] Evaluation of the impact of fistulizing disease on quality of life in Crohn's disease
    Kani, H. T.
    Ergenc, I
    Ozsarac, B.
    Sahin, B. N.
    Kaya, G.
    Ozutemiz, B.
    Demir, B. C.
    Atug, O.
    Alahdab, Y. Ozen
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1133 - I1133
  • [46] Infliximab induced endophthalmitis in a patient of fistulizing Crohn’s disease
    Rashi Kochhar
    Vishali Gupta
    Usha Dutta
    Kartar Singh
    Rakesh Kochhar
    Indian Journal of Gastroenterology, 2011, 30 (5) : 241 - 242
  • [47] Perianal Fistulizing Crohn’s Disease: No Shortcuts to a Deep Understanding of the Disease
    Jana G. Hashash
    Fadi H. Mourad
    Digestive Diseases and Sciences, 2021, 66 : 1392 - 1393
  • [48] Therapeutic Drug Monitoring in Perianal Fistulizing Crohn's Disease
    Zulqarnain, Mir
    Deepak, Parakkal
    Yarur, Andres J.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [49] Infliximab induced endophthalmitis in a patient of fistulizing Crohn's disease
    Kochhar, Rashi
    Gupta, Vishali
    Dutta, Usha
    Singh, Kartar
    Kochhar, Rakesh
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2011, 30 (05) : 241 - 242
  • [50] Meningitis and epidural abscess associated with fistulizing Crohn's disease
    Maggiore, R
    Miller, F
    Stryker, S
    Buchman, AL
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (09) : 1461 - 1465
12345